• May 3, 2012, 10:50 AM
    Kensey Nash (KNSY) surges 32% to $38.33, nearing the $38.50/share that Royal DSM (RDSMY.PK) is paying for the medical-device company.
    | May 3, 2012, 10:50 AM
  • May 3, 2012, 2:28 AM

    Kensey Nash (KNSY), a medical-device company focused on regenerative medicine, agrees to be bought by Royal DSM (RDSMY.PK) for $38.50/share, more than a 30% premium to Kensey Nash's close yesterday. (PR)

    | May 3, 2012, 2:28 AM
Company Description
DSM "Bright Science. Brighter Living." Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create... More
Industry: Chemicals - Major Diversified
Country: Netherlands